welcomes you to the new, improved website!A manuscript that wil certainly be discussed in lung MDT! The thought of a RCT in these earlier stages may be already in the mind of the sponsors… The authors do not report synergic side effects so far.
You are here:
Osimertinib with or without Chemotherapy in EGFR-Mutated Advanced NSCLC
Submitted by: Aristotle Protopapas
Source: The Bew England Journal of Medicine
Keywords:
Author(s): FLAURA2 Investigators
